Cargando…
Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
BACKGROUND: Drug-resistant tuberculosis (DR-TB), including rifampicin-resistant tuberculosis (RR-TB) and multidrug-resistant tuberculosis (MDR-TB, or RR-TB with additional isoniazid resistance), presents challenges to TB control. In Uganda, the GeneXpert test provides point-of-care testing for TB an...
Autores principales: | Bahizi, Gloria, Majwala, Robert Kaos, Kisaka, Stevens, Nyombi, Abdunoor, Musisi, Kenneth, Kwesiga, Benon, Bulage, Lilian, Ario, Alex Riolexus, Turyahabwe, Stavia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106164/ https://www.ncbi.nlm.nih.gov/pubmed/33964986 http://dx.doi.org/10.1186/s13756-021-00947-2 |
Ejemplares similares
-
Malaria outbreak in Mbale: it´s the pits! a case study
por: Kadobera, Daniel, et al.
Publicado: (2022) -
Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013–2017
por: Okethwangu, Denis, et al.
Publicado: (2019) -
Preparing for the worst: opportunities to prevent trans-boundary disease transmission in Uganda: a case study
por: Ario, Alex Riolexus, et al.
Publicado: (2022) -
Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
por: Mujuni, Dennis, et al.
Publicado: (2022) -
Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)